| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 29, 2026 | ±3.3% | +0.1% | over-priced |
| October 22, 2025 | ±2.8% | +4.1% | under-priced |
| July 24, 2025 | ±3.3% | +0.3% | over-priced |
| April 25, 2025 | ±3.7% | -1.2% | over-priced |
| October 23, 2024 | ±2.7% | +0.5% | over-priced |
| July 24, 2024 | ±2.7% | -2.1% | over-priced |
| April 24, 2024 | ±2.6% | -0.9% | over-priced |
| October 25, 2023 | ±3.5% | -0.7% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $0.50 | $8.7B | $761M |
| Q4 FY2025 | $0.55 | $9.7B | $800M |
| Q3 FY2025 | $0.50 | $8.9B | $774M |
| Q2 FY2025 | $0.74 | $8.5B | $1.0B |
SLB Limited (SLB) reports in 93 days, with the next report estimated for September 14, 2026. Across the last 8 reports, options priced an average ±3.1% earnings move while the stock actually moved 1.2% on average — the market has systematically over-priced SLB's earnings risk. Fundamentals into the print: EPS down 13.8% year-over-year, revenue up 2.7%. QuantLogix's live 5-factor engine currently reads SLB as a buy at 55/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →